Article
SPOP mutation confers sensitivity to AR-targeted therapy in prostate cancer by reshaping…
bioRxiv · 2021 · Ivana Grbesa
Key facts
| Title | SPOP mutation confers sensitivity to AR-targeted therapy in prostate cancer by reshaping the androgen-driven chromatin landscape |
|---|---|
| First author | Ivana Grbesa |
| Journal | bioRxiv |
| Published | Apr 23, 2021 |
| DOI | 10.1101/2021.04.20.440154 |
| Devices mentioned | K030528, K031042, K031044, K812133 |
| Product codes mentioned | FSM, JIY, KNK, LCP, JJQ, JQW, NJT, PFT |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1